These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 17134417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A, Iorizzo M, Botta GL, Milani M.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study.
    Di Fonzo EM, Martini P, Mazzatenta C, Lotti L, Alvino S.
    Mycoses; 2008 Nov; 51(6):532-5. PubMed ID: 18422916
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.
    Lee JH, Lee HS, Eun HC, Cho KH.
    J Dermatolog Treat; 2003 Dec; 14(4):212-5. PubMed ID: 14660265
    [Abstract] [Full Text] [Related]

  • 5. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA, Goode K.
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [Abstract] [Full Text] [Related]

  • 6. A double-blind randomized vehicle-controlled clinical trial investigating the effect of ZnPTO dose on the scalp vs. antidandruff efficacy and antimycotic activity.
    Bailey P, Arrowsmith C, Darling K, Dexter J, Eklund J, Lane A, Little C, Murray B, Scott A, Williams A, Wilson D.
    Int J Cosmet Sci; 2003 Aug; 25(4):183-8. PubMed ID: 18494899
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff--a postmarketing study.
    Saple DG, Ravichandran G, Desai A.
    J Indian Med Assoc; 2000 Dec; 98(12):810-1. PubMed ID: 11394481
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of a new synergized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: the ISAC study (Studio Della scabbia in ambiente carcerario).
    Biele M, Campori G, Colombo R, De Giorgio G, Frascione P, Sali R, Starnini G, Milani M, ISaC Investigator Group.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):717-20. PubMed ID: 16836502
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs. permethrin cream.
    Amerio P, Capizzi R, Milani M.
    Eur J Dermatol; 2003 Jul; 13(1):69-71. PubMed ID: 12609786
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial.
    Innocenzi D, Lupi F, Bruni F, Frasca M, Panetta C, Milani M.
    Curr Med Res Opin; 2005 Dec; 21(12):1949-53. PubMed ID: 16368045
    [Abstract] [Full Text] [Related]

  • 11. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis.
    Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE.
    Skin Pharmacol Appl Skin Physiol; 2002 Dec; 15(6):434-41. PubMed ID: 12476017
    [Abstract] [Full Text] [Related]

  • 12. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta AK, Abraham S, Rowell R.
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 14. Effect of residence time on the efficacy of antidandruff shampoos.
    Piérard-Franchimont C, Uhoda E, Loussouarn G, Saint-Léger D, Piérard GE.
    Int J Cosmet Sci; 2003 Dec; 25(6):267-71. PubMed ID: 18494909
    [Abstract] [Full Text] [Related]

  • 15. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 17. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, Schultz JC, Katz HI, McCormick CL, Parneix-Spake A.
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [Abstract] [Full Text] [Related]

  • 19. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.